Xenon Pharmaceuticals (XENE) Earnings
|
Expand Research on XENE
| Next EPS Date | 8/12/26 | EPS Growth Rate | -207.5% |
|---|---|---|---|
| Average EPS % Beat Rate | +49.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$1.15 | N/A | N/A | $1.5M | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | -$1.17 | -$1.18 | +$0.01 | N/A | $1.5M | N/A |  | | Details | |
| 2/26/26 | Q425 | -$1.31 | -$1.19 | -$0.12 | N/A | N/A | N/A | | | Details | |
| 11/3/25 | Q325 | -$1.15 | -$1.15 | $0.00 | N/A | N/A | N/A | | | Details | |
| 8/11/25 | Q225 | $1.07 | -$0.99 | +$2.06 | N/A | N/A | N/A | | | Details | |
| 5/13/25 |
Q125 | -$0.83 | -$0.91 | +$0.08 | $7.5M | $1.25M | N/A | | | Details | |
| 2/27/25 | Q424 | -$0.84 | -$0.85 | +$0.01 | N/A | $357.14K | N/A | | | Details | |
| 11/12/24 | Q324 | -$0.81 | -$0.82 | +$0.01 | N/A | N/A | N/A | | | Details |
